Allianz’s Gilead Sciences GILD Stock Holding History

Allianz’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$127K	Buy	1,006 +576	+134%	+$75.9K	﹤0.01%	407
2026 Q1	$59.9K	Sell	430 -5,040	-92%	-$706K	﹤0.01%	413
2025 Q4	$671K	Buy	5,470 +5,040	+1,172%	+$612K	0.01%	282
2025 Q3	$47.7K	Hold	430	–	–	﹤0.01%	334
2025 Q2	$47.7K	Sell	430 -62	-13%	-$6.6K	﹤0.01%	342
2025 Q1	$55.1K	Buy	492 +430	+694%	+$44.4K	﹤0.01%	355
2024 Q4	$5.71K	Sell	62 -14,025	-100%	-$1.26M	﹤0.01%	421
2024 Q3	$1.18M	Buy	14,087 +13,667	+3,254%	+$1.04M	0.03%	212
2024 Q2	$28.8K	Sell	420 -7,603	-95%	-$507K	﹤0.01%	413
2024 Q1	$588K	Buy	+8,023	New	+$617K	0.02%	254

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allianz's GILD Position: Q2 2026 in Review

Allianz increased its Gilead Sciences (GILD) stake by 134% in Q2 2026, buying an estimated $75.9K and bringing the position to 1,006 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Allianz first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.18M in Q3 2024. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Allianz held 1,006 shares of Gilead Sciences worth $127K as of Q2 2026.
Allianz bought 576 Gilead Sciences shares in Q2 2026, an estimated $75.9K.
Gilead Sciences made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #407 holding.
Allianz first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
Allianz's Gilead Sciences position peaked at $1.18M in Q3 2024.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.